PFO Closure Guidelines Address Older Adults, Trial-Excluded Groups Document acknowledges skimpy evidence May 19, 2022
Rare Seizure Disorder Treatments Continue to Expand New therapies reduce seizure frequency, but the biggest advancements may be on the horizon May 06, 2022
Vaping Doesn't Cut CV Risk for Those Who Also Smoke Combined use as bad for the heart as smoking alone May 06, 2022
FDA Proposes Ban on Menthol Cigarettes "Long-awaited action" should reduce youth smoking, health disparities Apr 28, 2022
Achilles' Tendon Rupture Surgery Not So Necessary? Randomized trial suggests one advantage despite similar outcomes to nonoperative treatment Apr 13, 2022
Home Walking Program Eases Peripheral Artery Disease Limitations Randomized trial shows modest impact even without in-facility supervision Apr 12, 2022
Clinical Challenges: Implementing More Guideline-Endorsed SGLT2i Use New strategies needed to ensure all are on board with fourth pillar of HF treatment Apr 11, 2022
Two PCI Guidance Strategies on Par for Intermediate Coronary Stenosis FLAVOUR trial weighs in on FFR versus IVUS Apr 05, 2022
Which Drug-Coated Balloon Proved Superior in Peripheral Artery Disease? Second-generation device goes head-to-head with popular first-gen device Apr 05, 2022
Study Provides 'Elusive' Link Between Kids' Health and Adult Heart Events CV risk factors in childhood tied to midlife CV events and CVD Apr 05, 2022